Lactylation signature identifies liver fibrosis phenotypes and traces fibrotic progression to hepatocellular carcinoma
- PMID: 39257588
- PMCID: PMC11383765
- DOI: 10.3389/fimmu.2024.1433393
Lactylation signature identifies liver fibrosis phenotypes and traces fibrotic progression to hepatocellular carcinoma
Abstract
Introduction: Precise staging and classification of liver fibrosis are crucial for the hierarchy management of patients. The roles of lactylation are newly found in the progression of liver fibrosis. This study is committed to investigating the signature genes with histone lactylation and their connection with immune infiltration among liver fibrosis with different phenotypes.
Methods: Firstly, a total of 629 upregulated and 261 downregulated genes were screened out of 3 datasets of patients with liver fibrosis from the GEO database and functional analysis confirmed that these differentially expressed genes (DEGs) participated profoundly in fibrosis-related processes. After intersecting with previously reported lactylation-related genes, 12 DEGs related to histone lactylation were found and narrowed down to 6 core genes using R algorithms, namely S100A6, HMGN4, IFI16, LDHB, S100A4, and VIM. The core DEGs were incorporated into the Least absolute shrinkage and selection operator (LASSO) model to test their power to distinguish the fibrotic stage.
Results: Advanced fibrosis presented a pattern of immune infiltration different from mild fibrosis, and the core DEGs were significantly correlated with immunocytes. Gene set and enrichment analysis (GSEA) results revealed that core DEGs were closely linked to immune response and chemokine signaling. Samples were classified into 3 clusters using the LASSO model, followed by gene set variation analysis (GSVA), which indicated that liver fibrosis can be divided into status featuring lipid metabolism reprogramming, immunity immersing, and intermediate of both. The regulatory networks of the core genes shared several transcription factors, and certain core DEGs also presented dysregulation in other liver fibrosis and idiopathic pulmonary fibrosis (IPF) cohorts, indicating that lactylation may exert comparable functions in various fibrotic pathology. Lastly, core DEGs also exhibited upregulation in HCC.
Discussion: Lactylation extensively participates in the pathological progression and immune infiltration of fibrosis. Lactylation and related immune infiltration could be a worthy focus for the investigation of HCC developed from liver fibrosis.
Keywords: hepatocellular carcinoma; immune infiltration; lactylation; liver fibrosis; machine learning.
Copyright © 2024 Li, Li, Xiao and Lai.
Conflict of interest statement
Author W-wL was employed by the company Guangzhou Wondfo Health Science and Technology Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures












Similar articles
-
Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis.Cancer Rep (Hoboken). 2024 Aug;7(8):e2152. doi: 10.1002/cnr2.2152. Cancer Rep (Hoboken). 2024. PMID: 39118438 Free PMC article.
-
Exploration of Key Genes Combining with Immune Infiltration Level andTumor Mutational Burden in Hepatocellular Carcinoma.Comb Chem High Throughput Screen. 2024;27(14):2110-2124. doi: 10.2174/0113862073239916231023053142. Comb Chem High Throughput Screen. 2024. PMID: 38213141
-
Identification of regulatory cell death-related genes during MASH progression using bioinformatics analysis and machine learning strategies.Front Immunol. 2025 May 8;16:1542524. doi: 10.3389/fimmu.2025.1542524. eCollection 2025. Front Immunol. 2025. PMID: 40406118 Free PMC article.
-
Lactate and lactylation in liver diseases: energy metabolism, inflammatory immunity and tumor microenvironment.Front Immunol. 2025 May 12;16:1581582. doi: 10.3389/fimmu.2025.1581582. eCollection 2025. Front Immunol. 2025. PMID: 40421024 Free PMC article. Review.
-
Epigenetic reprogramming in liver fibrosis and cancer.Adv Drug Deliv Rev. 2017 Nov 1;121:124-132. doi: 10.1016/j.addr.2017.10.011. Epub 2017 Oct 25. Adv Drug Deliv Rev. 2017. PMID: 29079534 Free PMC article. Review.
Cited by
-
Lactate-induced lactylation: from basic research to clinical perspectives.Front Pharmacol. 2025 Jun 13;16:1586973. doi: 10.3389/fphar.2025.1586973. eCollection 2025. Front Pharmacol. 2025. PMID: 40584617 Free PMC article. Review.
-
Diagnostic value of a lactylation-related gene signature in hepatocellular carcinoma.Transl Cancer Res. 2025 Jan 31;14(1):296-312. doi: 10.21037/tcr-24-1023. Epub 2025 Jan 23. Transl Cancer Res. 2025. PMID: 39974411 Free PMC article.
-
Multi-Omics Integration of Lactylation- and PANoptosis-Based Signatures in Lung Adenocarcinoma: Prognostic Stratification and Immune Response.Int J Mol Sci. 2025 Jun 23;26(13):5999. doi: 10.3390/ijms26135999. Int J Mol Sci. 2025. PMID: 40649778 Free PMC article.
-
The mitochondrial hub gene UCHL1 May serve as a potential biomarker for diagnosing diabetic cardiomyopathy: a comprehensive integration of biological pathways.BMC Med Genomics. 2025 Aug 11;18(1):129. doi: 10.1186/s12920-025-02199-0. BMC Med Genomics. 2025. PMID: 40790764 Free PMC article.
-
Targeting Lactylation: From Metabolic Reprogramming to Precision Therapeutics in Liver Diseases.Biomolecules. 2025 Aug 16;15(8):1178. doi: 10.3390/biom15081178. Biomolecules. 2025. PMID: 40867622 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous